SCHEMBL8660736

SCHEMBL8660736

Nc1nc2c(ncn2COCCOC(=O)c2ccccc2)c(=O)[nH]1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNP P00491 13/20 0.67
HBB P68871 2/20 0.67
BLM P54132 2/20 0.67
TSHR P16473 2/20 0.67
USP2 O75604 1/20 0.67
EDNRA P25101 1/20 0.67
HTR2A P28223 1/20 0.67
RECQL P46063 1/20 0.67
HSD17B10 Q99714 1/20 0.67
MEN1 O00255 3/20 0.66
KMT2A Q03164 3/20 0.66
MAPK1 P28482 1/20 0.65
HPRT1 P00492 3/20 0.61
POLG P54098 1/20 0.59
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
CYP3A4 P08684 1/20 0.53
NFKB1 P19838 1/20 0.53
VCP P55072 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11254814 0.94 PNP (0.65) PNPHBBBLMTSHRUSP2
SCHEMBL11260801 0.89 MEN1 (0.52) PNPHBBBLMTSHRUSP2
SCHEMBL10555421 0.87 MEN1 (0.55) PNPHBBBLMTSHRUSP2
SCHEMBL10481430 0.87 MEN1 (0.55) PNPHBBBLMTSHRUSP2
SCHEMBL1177727 0.86 PNP (0.65) PNPHBBBLMTSHRUSP2
SCHEMBL9836199 0.86 MEN1 (0.61) PNPHBBBLMTSHRUSP2
SCHEMBL8842488 0.85 PNP (0.66) PNPHBBBLMTSHRUSP2
SCHEMBL29370760 0.84 PNP (0.87) PNPHBBBLMTSHRUSP2
SCHEMBL9584377 0.84 BLM (0.66) PNPHBBBLMTSHRUSP2
SCHEMBL8842615 0.84 PNP (0.71) PNPHBBBLMTSHRUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4199574-A Methods and compositions for treating viral infections and guanine acyclic nucleosides BURROUGHS WELLCOME CO. (US) 1980-04-22 US claimed
US-5756737-A Process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine RECORDATI S.A. CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1998-05-26 US disclosed
EP-0717744-B1 A PROCESS FOR THE PREPARATION OF 9-(2-HYDROXY)-ETHOXYMETHYL-GUANINE RECORDATI CHEM PHARM (CH) 1997-05-07 EP disclosed
EP-0717744-A1 A PROCESS FOR THE PREPARATION OF 9-(2-HYDROXY)-ETHOXYMETHYL-GUANINE RECORDATI CHEM PHARM (CH) 1996-06-26 EP disclosed
WO-1995007281-A1 A PROCESS FOR THE PREPARATION OF 9-(2-HYDROXY)-ETHOXYMETHYL-GUANINE RECORDATI S.A. CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1995-03-16 WO disclosed
US-4360522-A VIRICIDES BURROUGHS WELLCOME CO. (US) 1982-11-23 US disclosed
US-4323573-A VIRICIDES BURROUGHS WELLCOME CO. (US) 1982-04-06 US disclosed
US-4294831-A ANTIVIRAL ACTIVITY BURROUGHS WELLCOME CO. (US) 1981-10-13 US disclosed
US-4287188-A PARTICULARLY 9-(2-HYDROXYETHOXYMETHYL) GUANINE MONOPHOSPHATE AND SALTS, USEFUL AS ANTIVIRIAL AGENTS BURROUGHS WELLCOME CO. (US) 1981-09-01 US disclosed
US-4199574-A Methods and compositions for treating viral infections and guanine acyclic nucleosides BURROUGHS WELLCOME CO. (US) 1980-04-22 US disclosed
US-4146715-A ANTIVIRAL AGENTS BURROUGHS WELLCOME CO. (US) 1979-03-27 US disclosed